104 related articles for article (PubMed ID: 26710756)
1. Absence of the BRAF V600E mutation in pheochromocytoma.
Paulsson JO; Svahn F; Welander J; Brunaud L; Söderkvist P; Gimm O; Stenman A; Juhlin CC
J Endocrinol Invest; 2016 Jun; 39(6):715-6. PubMed ID: 26710756
[TBL] [Abstract][Full Text] [Related]
2. Absence of BRAF mutation in pheochromocytoma and paraganglioma.
Vosecka T; Vicha A; Zelinka T; Jencova P; Pacak K; Duskova J; Benes J; Guha A; Stanek L; Kohoutova M; Musil Z
Neoplasma; 2017; 64(2):278-282. PubMed ID: 28043156
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
Stenman A; Svahn F; Welander J; Gustavson B; Söderkvist P; Gimm O; Juhlin CC
Endocr Pathol; 2015 Mar; 26(1):9-14. PubMed ID: 25403449
[TBL] [Abstract][Full Text] [Related]
4. Adult classical glioblastoma with a BRAF V600E mutation.
Takahashi Y; Akahane T; Sawada T; Ikeda H; Tempaku A; Yamauchi S; Nishihara H; Tanaka S; Nitta K; Ide W; Hashimoto I; Kamada H
World J Surg Oncol; 2015 Mar; 13():100. PubMed ID: 25885250
[TBL] [Abstract][Full Text] [Related]
5. The occurrence of SDHB gene mutations in pheochromocytoma.
Van Nederveen FH; Dinjens WN; Korpershoek E; De Krijger RR
Ann N Y Acad Sci; 2006 Aug; 1073():177-82. PubMed ID: 17102084
[TBL] [Abstract][Full Text] [Related]
6. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
8. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
Capper D; Preusser M; Habel A; Sahm F; Ackermann U; Schindler G; Pusch S; Mechtersheimer G; Zentgraf H; von Deimling A
Acta Neuropathol; 2011 Jul; 122(1):11-9. PubMed ID: 21638088
[TBL] [Abstract][Full Text] [Related]
9. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics.
Karamzadeh Dashti N; Bahrami A; Lee SJ; Jenkins SM; Rodriguez FJ; Folpe AL; Boland JM
Am J Surg Pathol; 2017 Nov; 41(11):1532-1541. PubMed ID: 28834810
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.
Affolter K; Samowitz W; Tripp S; Bronner MP
Genes Chromosomes Cancer; 2013 Aug; 52(8):748-52. PubMed ID: 23650027
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
[TBL] [Abstract][Full Text] [Related]
14. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
[TBL] [Abstract][Full Text] [Related]
15. Expression of BRAF V600E mutant protein in epithelial ovarian tumors.
Preusser M; Capper D; Berghoff AS; Horvat R; Wrba F; Schindl M; Schoppmann SF; von Deimling A; Birner P
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):159-64. PubMed ID: 22820660
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
Juhlin CC; Stenman A; Haglund F; Clark VE; Brown TC; Baranoski J; Bilguvar K; Goh G; Welander J; Svahn F; Rubinstein JC; Caramuta S; Yasuno K; Günel M; Bäckdahl M; Gimm O; Söderkvist P; Prasad ML; Korah R; Lifton RP; Carling T
Genes Chromosomes Cancer; 2015 Sep; 54(9):542-54. PubMed ID: 26032282
[TBL] [Abstract][Full Text] [Related]
17. BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR.
Jeong D; Jeong Y; Park JH; Han SW; Kim SY; Kim YJ; Kim SJ; Hwangbo Y; Park S; Cho HD; Oh MH; Yang SH; Kim CJ
Ann Surg Oncol; 2013 Mar; 20(3):759-66. PubMed ID: 23179992
[TBL] [Abstract][Full Text] [Related]
18. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
19. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
[TBL] [Abstract][Full Text] [Related]
20. Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry.
Méhes G; Irsai G; Bedekovics J; Beke L; Fazakas F; Rózsa T; Kiss C
Am J Surg Pathol; 2014 Dec; 38(12):1644-8. PubMed ID: 25118810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
